Clinical Trials in Nashville

Showing 17641-17660 of 20,298 trials

SJG-136 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery

NCT00121290

This phase I trial studies the side effects and best dose of SJG-136 in treating patients with solid tumors that are metastatic or cannot be removed by surgery. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.

Unspecified Adult Solid Tumor, Protocol Specific

National Cancer Institute (NCI)39 participantsStarted Feb 2005

Nashville, Tennessee, United States

WITHDRAWNPhase 2/3< 1 mile

Randomized Controlled Trial of Silymarin in Asthma

NCT01049178

The purpose of this study is to determine if intake of the antioxidant enzyme inducer, silymarin, will improve lung function and symptom scores in participants with asthma.

Atopic Asthma

Vanderbilt UniversityStarted Sep 2010

Nashville, Tennessee, United States

COMPLETEDPhase 3< 1 mile

A 1-year Study in Adolescents to Assess the Long-term Safety of Almotriptan Malate When Treating Their Migraine Headaches

NCT00257010

The purpose of this study is to evaluate the long-term safety of almotriptan malate (a migraine headache medication) in the treatment of migraine headaches in adolescents for up to one year.

Migraine

Janssen-Ortho LLC447 participantsStarted Dec 2005

Mobile, Alabama, United States • Montgomery, Alabama, United States • Oxford, Alabama, United States +46 more locations

SJG-136 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery

Randomized Controlled Trial of Silymarin in Asthma

A 1-year Study in Adolescents to Assess the Long-term Safety of Almotriptan Malate When Treating Their Migraine Headaches

Find Trials by Condition in Nashville

Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma

Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes

Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy

An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma

Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia

Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease

DPBRN Longitudinal Study of Questionable Occlusal Caries Lesions

Comparison of Different Combination Chemotherapy Regimens in Treating Infants With Acute Lymphoblastic Leukemia

Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune®

Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer

Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors

Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer

Gene Transfer for Cancer Pain

A Placebo and Active Controlled Study of ONO-6950 in Asthmatic Patients

Transforming Research and Clinical Knowledge in TBI Pilot